The U.S. Department of Health and Human Services recently released a new subset of objectives and a new set of health measures as part of the Healthy People 2030 initiative: Leading Health Indicators (LHIs) and Overall Health and Well-Being Measures (OHMs). Together, LHIs and OHMs will help public health and healthcare professionals, businesses, policymakers, national organizations, and community leaders set priorities and track nationwide progress toward improving health and well-being. Many LHIs address the leading causes of death and disease in the United States — including drug overdoses.
The Milbank Memorial Fund recently released a primer that examines the policy levers available to improve access and quality of substance use disorder (SUD) treatment and recovery services. As the nation’s largest payer for SUD treatment and recovery services, Medicaid plays a significant role in shaping the delivery and reimbursement of such services not only for the program’s beneficiaries but more broadly for commercially insured and Medicare populations. Nationally, Medicaid covers nearly 40% of all individuals with an opioid use disorder. Medicaid plays an even larger role for high-risk populations with SUDs, including pregnant women and justice-involved persons who are disproportionally insured by Medicaid.
The Provider Clinical Support System is requesting input for a survey that assesses provider preparedness and experience with patient drug overdose deaths. This survey is geared toward physicians, nurses, PAs, NPs, psychologists, social workers, counselors or other professions that provides direct client care. This information will be used to guide future training content.
To take the survey, click here.
|